AbbVie is pleased to share videos looking into the cumulative impact of psoriasis on patients’ lives and the importance of achieving and maintaining clear or almost clear skin (PASI 90/100) to optimise improvements in patients’ quality of life (QoL).
Please click the images below to view videos:
Unmet need in psoriasis as a chronic disease
Chronic conditions can exert a cumulative negative impact over a lifetime trajectory, influencing an individual’s ability to optimally fulfil their life potential. This concept is known as cumulative life course impairment (CLCI). Striving to achieve and maintain clear or almost clear skin (PASI 90/100) is important in optimising patients' quality of life and reducing the impact of CLCI1.
1. Warren RB, et al. Br J Dermatol. 2011 May;164 Suppl 1:1-14.
2. Rasmussen MK, et al. Acta Derm Venereol. 2019 Feb 1;99(2):158-163.
3. Girolomoni G, et al. J Eur Acad Dermatol Venereol. 2017;31(10):1616-1626. .
ABBV-AU-00083-MC- Created May 2022
Copyright © 2022 AbbVie Pty Ltd. Mascot NSW 2020 Australia.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates.
No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.